Business Context and Reporting Period
CareDx, Inc. filed this Form 8-K to report the results of its 2016 Annual Meeting of Stockholders held on June 16, 2016. The company is incorporated in Delaware and maintains its principal executive offices in Brisbane, California.
Key Financial Metrics
This filing is a current report regarding corporate governance and shareholder voting. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data.
Material Changes
The filing details the outcome of three shareholder proposals:
- Director Election: Stockholders elected two Class II directors, Fred E. Cohen and William A. Hagstrom, to serve until the 2019 annual meeting.
- Accounting Firm Ratification: Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2016.
- Share Issuance Approval: Stockholders approved the issuance of shares in connection with equity financings as required by NASDAQ Listing Rule 5635. This included 926,029 shares of common stock, 4,630,145 shares issuable upon conversion of Series A Mandatorily Convertible Preferred Stock, and 2,978,087 shares issuable upon the exercise of warrants at prices of $4.98 and $3.99 per share.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, risks, contingencies, or unusual items. The document is limited to the reporting of voting results.
Investor Verification Checklist
- Verify the total number of shares outstanding (13,960,762 as of the April 18, 2016 record date) and the quorum status (77.46% represented).
- Confirm the specific vote counts for the election of directors Fred E. Cohen and William A. Hagstrom.
- Review the specific share counts approved for issuance under the Series A Preferred Stock conversion and warrant exercises to assess potential dilution.
- Confirm the appointment of Ernst & Young LLP for the fiscal year ending December 31, 2016.